| 1. |
New concept suggests link between antibacterial dosing and resistance |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
Inconsistencies between UK NICE, BHS hypertension guidelines |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Use of prescription drugs among fathers around the time of conception is common in Denmark and The Netherlands, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Azithromycin microspheres equivalent to standard therapy for RTIs |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 5-6
N Moreland,
Preview
|
|
摘要:
A single dose of azithromycin microspheres is as effective as standard multiple-dose antibacterial therapies in the treatment of respiratory tract infections (RTIs), according to results from three pivotal studies presented at the 44th Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) [Washington DC, US; October−November 2004]. In each of these studies, which involved a total of over > 1500 patients, clinical success rates were comparable among those who received a single dose of azithromycin microspheres and patients who received a 7- or 10-day course of a comparator antibacterial. Furthermore, bacteriological eradication rates were similar for azithromycin microspheres and the comparators.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Lumiracoxib as effective as celecoxib in knee OA |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Prophylactic vs curative ibuprofen in premature neonates |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
Sirolimus withdrawal improves calcineurin-inhibitor nephrotoxicity |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Mycophenolate mofetil a promising alternative in lupus |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 9-10
S Sullivan,
Preview
|
|
摘要:
Mycophenolate mofetil [CellCept] is effective in the treatment of lupus, according to studies presented at the 68th Scientific Meeting of the American College of Rheumatology (ACR) [San Antonio, US; October 2004]. In one of these studies, patients with nonrenal systemic lupus erythematosus (SLE) had an improvement in symptoms and were able to reduce their dose of prednisone after 6 months of treatment with mycophenolate mofetil. A study evaluating the effects of mycophenolate mofetil in patients with lupus nephritis showed that oral mycophenolate mofetil was as effective as IV cyclophosphamide in inducing disease remission. Patients with lupus membranous glomerulonephritis experienced a beneficial response to mycophenolate mofetil and were also able to reduce the dose of prednisone required.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
Rosuvastatin improves serum lipid profiles in postmenopausal women with hypercholesterolaemia who are receiving HRT, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Long-term treatment with alendronic acid prevents bone loss in early-postmenopausal women, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1466,
2004,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
